Verrica Pharmaceuticals Inc. (VRCA) — Institutional Holders, Q2 2026
44 institutional investment managers reported a VRCA position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $28.8M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
VRCA in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- MarinerAdded · +182,686 sh+$1.1M
- CANNELL CAPITALAdded · +98,800 sh+$604.7K
- VANGUARD CAPITAL MANAGEMENTAdded · +90,552 sh+$554.2K
- BlackRockAdded · +35,791 sh+$219.0K
- FIFTH THIRD BANCORPNew · +14,000 sh+$85.7K
Biggest sellers
- MARSHALL WACE, LLPSold out · -140,497 sh-$859.8K
- DAFNA Capital ManagementTrimmed · -129,962 sh-$795.4K
- ARMISTICE CAPITALTrimmed · -91,877 sh-$562.3K
- Squarepoint OpsSold out · -75,208 sh-$460.3K
- JANE STREET GROUPTrimmed · -25,557 sh-$156.4K
VRCA 13F holders ranked 1–44 of 44
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Caligan Partners#1 · 923,910 sh | 923,910 | $5.7M | 0.27% | 0.0% |
| 2 | CANNELL CAPITAL#2 · 783,923 sh | 783,923 | $4.8M | 3.22% | +14.4% |
| 3 | Affinity Asset Advisors#3 · 707,338 sh | 707,338 | $4.3M | 0.20% | 0.0% |
| 4 | Velan Capital Investment Management#4 · 471,559 sh | 471,559 | $2.9M | 1.76% | 0.0% |
| 5 | ARMISTICE CAPITAL#5 · 426,304 sh | 426,304 | $2.6M | 0.03% | -17.7% |
| 6 | BOOTHBAY FUND MANAGEMENT#6 · 280,734 sh | 280,734 | $1.7M | 0.02% | 0.0% |
| 7 | VANGUARD CAPITAL MANAGEMENT#7 · 279,310 sh | 279,310 | $1.7M | 0.00% | +48.0% |
| 8 | Mariner#8 · 207,230 sh | 207,230 | $1.3M | <0.01% | +744.3% |
| 9 | GEODE CAPITAL MANAGEMENT#9 · 138,160 sh | 138,160 | $845.7K | 0.00% | -0.5% |
| 10 | BlackRock#10 · 74,344 sh | 74,344 | $455.0K | 0.00% | +92.8% |
| 11 | VANGUARD FIDUCIARY#11 · 70,173 sh | 70,173 | $429.5K | <0.01% | +7.8% |
| 12 | TWO SIGMA INVESTMENTS#12 · 40,825 sh | 40,825 | $249.8K | <0.01% | -19.4% |
| 13 | Stonepine Capital Management#13 · 88,417 sh | 88,417 | $241.5K | 0.11% | -11.3% |
| 14 | STATE STREET#14 · 28,916 sh | 28,916 | $177.0K | 0.00% | 0.0% |
| 15 | NORTHERN#15 · 26,996 sh | 26,996 | $165.2K | 0.00% | -14.5% |
| 16 | DAFNA Capital Management#16 · 23,750 sh | 23,750 | $145.3K | 0.03% | -84.5% |
| 17 | JANE STREET GROUP#17 · 23,654 sh | 23,654 | $144.8K | 0.00% | -51.9% |
| 18 | Verdad Advisers#18 · 23,069 sh | 23,069 | $141.2K | 0.14% | +90.7% |
| 19 | RENAISSANCE TECHNOLOGIES#19 · 21,769 sh | 21,769 | $133.2K | <0.01% | -32.7% |
| 20 | Legacy#20 · 16,584 sh | 16,584 | $101.5K | 0.02% | -3.8% |
| 21 | FIFTH THIRD BANCORP#21 · 14,000 sh | 14,000 | $85.7K | <0.01% | New |
| 22 | DIMENSIONAL FUND ADVISORS#22 · 13,888 sh | 13,888 | $85.0K | 0.00% | New |
| 23 | XTX Topco Ltd#23 · 13,723 sh | 13,723 | $84.0K | <0.01% | New |
| 24 | TWO SIGMA SECURITIES#24 · 13,045 sh | 13,045 | $79.8K | <0.01% | New |
| 25 | HRT FINANCIAL#25 · 13,023 sh | 13,023 | $79.0K | <0.01% | New |
| 26 | BECK MACK & OLIVER#26 · 12,000 sh | 12,000 | $73.4K | <0.01% | 0.0% |
| 27 | UBS Group AG#27 · 6,071 sh | 6,071 | $37.2K | 0.00% | +42.2% |
| 28 | MORGAN STANLEY#28 · 3,201 sh | 3,201 | $19.6K | 0.00% | -85.7% |
| 29 | Capital Analysts#29 · 1,500 sh | 1,500 | $9.0K | <0.01% | 0.0% |
| 30 | Vanguard Global Advisers#30 · 862 sh | 862 | $5.3K | 0.00% | 0.0% |
| 31 | ROYAL BANK OF CANADA#31 · 764 sh | 764 | $5.0K | 0.00% | -20.8% |
| 32 | Tower Research Capital (TRC)#32 · 614 sh | 614 | $3.8K | <0.01% | -28.3% |
| 33 | Salomon & Ludwin#33 · 290 sh | 290 | $1.7K | <0.01% | 0.0% |
| 34 | Allied Private Wealth#34 · 202 sh | 202 | $1.3K | <0.01% | — |
| 35 | New England Capital Financial Advisors#35 · 200 sh | 200 | $1.2K | <0.01% | 0.0% |
| 36 | INTERNATIONAL ASSETS INVESTMENT MANAGEMENT#36 · 175 sh | 175 | $1.0K | <0.01% | 0.0% |
| 37 | Fortitude Family Office#37 · 127 sh | 127 | $777.00 | — | 0.0% |
| 38 | BNP PARIBAS FINANCIAL MARKETS#38 · 110 sh | 110 | $673.00 | 0.00% | 0.0% |
| 39 | PNC FINANCIAL SERVICES GROUP#39 · 102 sh | 102 | $624.00 | 0.00% | 0.0% |
| 40 | BARCLAYS PLC#40 · 64 sh | 64 | $392.00 | 0.00% | New |
| 41 | JPMORGAN CHASE#41 · 47 sh | 47 | $306.00 | 0.00% | 0.0% |
| 42 | Ameritas Advisory Services#42 · 30 sh | 30 | $184.00 | 0.00% | New |
| 43 | JONES FINANCIAL COMPANIES LLLP#43 · 26 sh | 26 | $178.00 | 0.00% | 0.0% |
| 44 | VALLEY NATIONAL ADVISERS#44 · 25 sh | 25 | $153.00 | — | New |
Funds that sold out of VRCA in Q2 2026 (4)
Held VRCA at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| MARSHALL WACE, LLP140,497 sh | 140,497 | $743.2K |
| Squarepoint Ops75,208 sh | 75,208 | $397.9K |
| Optiver Holding B.V.31 sh | 31 | $164.00 |
| MAI Capital Management2 sh | 2 | $11.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.